Transfer factor — development and research of new pharmaceutical form (Q11224)

From EU Knowledge Graph
Revision as of 19:11, 15 July 2020 by DG Regio (talk | contribs) (‎Changed an Item)
Jump to navigation Jump to search
Project in Czech Republic financed by DG Regio
Language Label Description Also known as
English
Transfer factor — development and research of new pharmaceutical form
Project in Czech Republic financed by DG Regio

    Statements

    contained in NUTS
    Prague
    0 references
    country
    Czechia
    0 references
    EU contribution
    24,083,996.56 Czech koruna
    0 references
    963,359.8624 Euro
    exchange rate to Euro
    0.04 Euro
    point in time
    10 January 2020
    0 references
    budget
    43,285,400.0 Czech koruna
    0 references
    1,731,416.0 Euro
    exchange rate to Euro
    0.04 Euro
    point in time
    10 January 2020
    0 references
    co-financing rate
    55.64 percent
    0 references
    start time
    16 April 2018
    0 references
    expected end time
    30 April 2020
    0 references
    beneficiary name (string)
    AUMED, a.s.
    0 references
    beneficiary
    Q198505
    0 references
    coordinate location

    49°59'56.22"N, 14°25'3.50"E
    0 references
    postal code
    14300
    0 references
    summary
    Předložený projekt řeší problematiku přípravy nové lékové formy specifických imunomodulátorů na bázi transfer faktorů (TF) a metod testování jejich imunobiologického potenciálu a. (Czech)
    0 references
    The proposed project addresses the preparation of a new pharmaceutical form of specific immunomodulators based on transfer of factors (TF) and methods of testing their immunobiortic potential. (English)
    0 references

    Identifiers

    Czech Kohesio ID
    CZ.01.1.02/0.0/0.0/16_083/0010301
    0 references
     
    Retrieved from "https://linkedopendata.eu/w/index.php?title=Item:Q11224&oldid=4582211"